<!DOCTYPE html>
<html lang="zh">
<head>
    <meta charset="UTF-8">
    <meta name="keywords" content=""/>
    <meta name="description" content="" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <link rel="icon" href="./../../themes/halo_quickstarter/source/images/favicon.ico" type="image/x-icon" />
	<link rel="stylesheet" type="text/css" href="./../../themes/halo_quickstarter/source/plug/css.css">
	<link rel="stylesheet" href="./../../themes/halo_quickstarter/source/css/kico.css"/>
	<link rel="stylesheet" href="./../../themes/halo_quickstarter/source/css/hingle.css"/>
	<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css"/>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/jquery.min.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/js.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/Top.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/time.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/count.js"></script>
	<!--script type="text/javascript" src="//api.html5media.info/1.2.2/html5media.min.js"></script-->
	<script type="text/javascript" id="wow"></script> 
	<script>
		$(function(){
			$(".li5").click(function() {
				$("html,body").animate({scrollTop:0}, 1000);
			});
		})
	</script>
    <meta name="generator" content="Halo 1.5.4"/>
    

    <meta name="referrer" content="never"><title>2025Biotech洗牌:百济、信达的分野与进击 展会快讯</title>
</head>
<!--##单页模块##-->
<body style="background-color: #ffffff">

<!--##pagetop##-->
<div class="header">
	<div class=" juzhong hidden-xs por DingBu" style="background-image:url(./../../upload/images/PcHead.jpg);background-color: #ced3d6;">
	</div>
</div>
<div id="nav-bar" class="clearfix">



	<div class="M-Nav" id="logo"> 
		<a href="#" class="Logo visible-xs"><img src="./../../upload/images/PhoneHead.jpg" alt="2023大湾区工博会- DMP大湾区工业博览会-深圳工博会"></a> 
	</div>
	<a href="javascript:;" class="M-Nav-btn"><div id="ToIndex"></div></a>
	<a href="./../.."  class="M-Nav-btn"><div id="ToIndex02"></div></a>
	<div id="nav">
			<ul>
			<li><a href="./../../index.html" target="_self">首页</a>
			</li>
			<li><a href="./../657ad54dae22ffa0bfc49574a0e55ec1####/index.html" target="_self">关于展会</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="./../../s/exhibition-summary/index.html" target="_self">展会介绍</a></li>
					<li><a href="./../../s/exhibition-hall/index.html" target="_self">展馆介绍</a></li>
					<li><a href="./../../s/中部工博会/index.html" target="_self">南昌工博会</a></li>
					<li><a href="./../../s/福州工博会/index.html" target="_self">福州工博会</a></li>
					<li><a href="./../../api/DMP香港工博会2023.pdf" target="_blank">香港工博会</a></li>
					<li><a href="/xt/cn/" target="_blank">展会展期</a></li>
				</ul>
			</div>
			</li>
			<li><a href="./../657ad54dae22ffa0bfc49574a0e55ec1####/index.html" target="_self">参展商</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="./../../categories/brand/index.html" target="_self">品牌榜</a></li>
					<li><a href="https://admin.dwqgbh.cn/nav/guestbook.htm" target="_self">展位申请</a></li>
				</ul>
			</div>
			</li>
			<li><a href="./../../categories/index.html" target="_self">新闻中心</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="./../../categories/message/index.html" target="_self">信息发布</a></li>
					<li><a href="./../../media/index.html" target="_self">媒体聚焦</a></li>
					<li><a href="./../index.html" target="_self">展会快讯</a></li>
					<li><a href="//tech.dwqgbh.cn/news/" target="_self">科技前沿资讯</a></li>
				</ul>
			</div>
			</li>
			<li><a href="./../../s/about/index.html" target="_self">关于我们</a>
			</li>
			<li><a href="./../657ad54dae22ffa0bfc49574a0e55ec1####/index.html" target="_self">联系我们</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="https://admin.dwqgbh.cn/nav/guestbook.htm" target="_self">展位申请</a></li>
					<li><a href="./../../s/individual/index.html" target="_self">观众报名</a></li>
					<li><a href="./../.." target="_self">✆137-6147-0961</a></li>
					<li><a href="mailto:1301150027@qq.com" target="_self">1301150027@qq.com</a></li>
				</ul>
			</div>
			</li>
			</ul>
	</div>


</div>
<div class="nav-bar-height visible-xs"></div>


<main>
    <div class="wrap min">
               
    <h2 style="text-align:center">2025Biotech洗牌:百济、信达的分野与进击 </h2>
   <p style="text-align:center">MedTrend医趋势  2025-04-18</p>
   <article class="post-content">
   
    <section><span leaf=""><img alt="图片" data-imgfileid="513694955" data-ratio="0.24375" data-src="https://mmbiz.qpic.cn/sz_mmbiz_gif/0kAgTXnvfia8XqnjyRicoK2LI4bGPa9F71CGaKYVQ2IoRTib5Z6R5ug5O5LoCYlVVVmDzmh8mTKd0yicqzpbibteb9g/640?wx_fmt=gif&from=appmsg&wxfrom=5&wx_lazy=1&wx_co=1&tp=webp" data-type="gif" data-w="640" class="src" src="./../../static/load.gif"/></span><span leaf=""><br/></span></section><section><span mpa-font-style="m8xy3wdhw51"><span data-pm-slice="0 0 []"><span mpa-font-style="m8xy3wdhw51"><span data-pm-slice="0 0 []"/></span></span></span></section><section data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span mpa-font-style="m8xy3wdhw51"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span leaf="">2025年，Biotech行业整体面临激烈的竞争与分化。</span></span></span></span></span></section><section data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span mpa-font-style="m8xy3wdhw51"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span leaf="">一方面，众多Biotech企业仍在生存发展边</span><span leaf="">缘挣扎，</span><span leaf="">实现重大突破的难度有所上升。另一方面，两家近乎同岁的代表性Biotech——<span textstyle="">百济神州</span>与<span textstyle="">信达生物</span>（分别创立于2010年和2011年），凭借各自独特的战略抉择和发展路径，都站在盈利门槛之上，成为行业瞩目的焦点。</span></span></span></span></span><span><p/></span></section><p><span leaf="">2010年，王晓东与欧雷强创立百济神州；2011年，俞德超在苏州成立信达生物。当时中国创新药行业仍处于起步阶段，发展相对缓慢，两家企业的创立仿佛开启了命运的新篇章，开始在创新药领域探索前行。</span></p><p><span leaf="">在创立初期的数年里，两家公司<span textstyle="">不约而同</span>地选择了</span><span leaf=""><span textstyle="">PD-1靶点</span></span><span leaf="">作为研发方向，作为创新药领域的探索者，先后实现了产品的商业化成功。2018年，港交所18A新政</span><font face="微软雅黑"><span leaf="">发布</span></font><font face="微软雅黑"><span leaf="">，信达与百济<span textstyle="">几乎同时</span>叩响上市铜锣。</span></font><span><p/></span></p><p><font face="微软雅黑"><span leaf="">然而，<span textstyle="">看似并行的轨迹下，裂痕正在滋生</span>。</span></font><span><span leaf=""><br/></span></span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">当信达选择与礼来联姻，将</span></font><span leaf="">PD-1海外权益换取生存所需的现金流时，百济则耗费8亿美元，将全新生产基地和临床研发中心建到新泽西州。</span></p><p><span leaf="">这对曾经的“抗癌兄弟连”，在资本市场渐行渐远：一个化身精明的本土Biotech，在国内市场攻城略地；一个将之前的BeiGene换成了BeOne Medicines，冲击全球创新高地。</span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">如今回望，</span></font><span leaf="">2018年那个飘雪的上市夜，或许早已预示了分野——信达敲钟时所展示的是装满医保目录的红头文件，而百济展台上摆放的，是一张泛黄的马萨诸塞州地铁票，那是王晓东当年往返MIT实验室的车票。</span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">如今百济市值超</span></font><span leaf=""><span textstyle="">3333亿元</span>，成为中国版“MNC”；信达达到<span textstyle="">779亿元</span>，打造国产Biotech"顶流"。<span textstyle="">Biotech造梦的故事，百济神州与信达实现了，代表了两种截然不同的路径</span>。</span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">但</span></font><b><font face="微软雅黑"><span leaf=""><span textstyle="">世间再无百济</span></span></font><span leaf=""><span textstyle="">/信达第二</span></span></b><font face="微软雅黑"><span leaf="">，这样的故事两人</span></font><b><font face="微软雅黑"><span leaf="">也<span textstyle="">走过了</span></span></font><span leaf=""><span textstyle="">15年</span></span></b><font face="微软雅黑"><span leaf="">。对于一众</span></font><span leaf="">Biotech而言，生存命题，从未如此锋利。</span></p><p data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span leaf=""><br/></span></span></span></span></span></span></p><section data-pm-slice="0 0 []"><span><strong><span><span leaf="">01</span></span></strong></span></section><p><span><strong><span><strong><span leaf="" data-pm-slice="1 1 ["para",{"tagName":"h3","attributes":{"style":"-webkit-tap-highlight-color: transparent; margin: 0px 16px 24px; padding: 0px; outline: 0px; max-width: 100%; color: rgba(0, 0, 0, 0.9); font-family: \"PingFang SC\", system-ui, -apple-system, \"system-ui\", \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif; font-size: 17px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.544px; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; background-color: rgb(255, 255, 255); line-height: 1.5em; visibility: visible; box-sizing: border-box !important; overflow-wrap: break-word !important;","data-pm-slice":"0 0 []"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"strong","attributes":{"style":null},"namespaceURI":"http://www.w3.org/1999/xhtml"}]">信达向左、百济朝右</span></strong></span></strong></span></p><p><span><strong><span><span leaf=""><br/></span></span></strong></span></p><p><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/0kAgTXnvfia9rVsk9b8K2wMxO8FicFON4CiazHK2oGvgaVcyxsxmaQlXyIqOemr8ILMnM0oCjEGSxYnshGDP7icwCw/640?wx_fmt=png&from=appmsg" class="rich_pages wxw-img src" data-ratio="0.8175925925925925" data-s="300,640" data-type="png" data-w="1080" type="block" data-imgfileid="513695951" src="./../../static/load.gif"/></span></p><p><span leaf="">2018年，信达生物头顶“首个PD-1单抗即将获批”标签登陆港交所，百济神州则带着"首个美股、港股双重上市中国药企"的光环登场。彼时，市场将两者视为中国创新药双子星，<span textstyle="">却未察觉两者战略底色的根本差异</span>。</span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">信达生物创始人俞德超的职业生涯始于国内生物制药产业化浪潮，其创办的信达生物天然<span textstyle="">带有</span></span></font><span leaf=""><span textstyle="">"中国式创新"的务实基因</span>——聚焦国内临床需求，追求快速商业化闭环。</span></p><p><span leaf="">而百济神州创始人王晓东（美国科学院院士）与欧雷强（生物医药连续创业者）的组合，则从一开始就锚定"全球新"（First-in-class）的野心。王晓东实验室背景赋予百济对基础科学的执着，更有对<span textstyle="">全球顶尖科研体系的路径依赖</span>。</span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">二者展现了<span textstyle="">现金流优先</span>与<span textstyle="">风险溢价</span>的博弈。</span></font><span><span leaf=""><br/></span></span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">信达更多聚焦中国医保谈判及商业化，抢占国内市场，国际化投入相对保守。目前信达有</span></font><span leaf=""><span textstyle="">15款</span>产品获批，但尚未有产品进入海外市场。从信达将PD-1海外权益授权礼来，本质是选择"<span textstyle="">确定性现金流优先</span>"，支撑后续管线开发。</span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">百济</span></font><font face="微软雅黑"><span leaf="">并</span></font><font face="微软雅黑"><span leaf="">没有遵循<span textstyle="">武田</span>、<span textstyle="">恒瑞</span>那般从一家靠成熟</span></font><span leaf="">&仿制药业务起家、再逐渐转型创新药企的发展路径</span><font face="微软雅黑"><span leaf="">；而是更像</span></font><font face="微软雅黑"><span leaf=""><span textstyle="">再生元</span>、<span textstyle="">吉利德</span>那般，依托于美国医疗市场滋养出来的</span></font><span leaf="">biotech</span><font face="微软雅黑"><span leaf="">。再加上，</span></font><font face="微软雅黑"><span leaf="">其一直以来享受着来自中国的创新药时代红利和华尔街资本的双重灌溉，并逐渐淡化自己的地域属性，强调自己是一家全球化的公司。</span></font><span><p/></span></p><p><font face="微软雅黑"><span leaf="">从战略来看，信达生物是</span></font><font face="微软雅黑"><span leaf="">紧密围绕<span textstyle="">医疗支付体系</span>，通过</span></font><span leaf="">PD-1<span textstyle="">医保谈判</span>快速放量，并在医保控费框架内构</span><span leaf="">建“仿创结合”的管线组合。另外，通过适应症扩展、授权合作和高价值创新药布局，实现了商业可持续性。</span></p><p><span leaf="">而百济则试图突破中国创新药的"<span textstyle="">定价天花板</span>"：泽布替尼美国的定价是国内医保定价的<span textstyle="">10倍</span>，贴近O药和K药定价，这种对标国际巨头的打法，本质上是对全球创新药价值分配体系的正面冲击。</span></p><p><span leaf="">另外，在管理团队上，信达是高度本土化，决策链条紧贴国内政策风向，而百济构建的则是"中美双核驱动"架构。</span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">当然，更深层差异在于对<span textstyle="">中国创新药未来路径的认知分野</span>。信达遵循的是</span></font><span leaf="">"<span textstyle="">市场换技术</span>"的改良主义：通过国际合作获取技术溢出，在本土市场完成价值闭环。而百济选择的是"<span textstyle="">技术换市场</span>"的激进路线：从源头创新突破，直接参与全球规则制定。</span></p><p><span leaf="">这两种路径恰似中国产业升级的缩影——</span><b><font face="微软雅黑"><span leaf=""><span textstyle="">如果说走全球化战略的百济神州代表着大多数中国创新药企的理想，那么扎根本土的信达生物体现的更多或许是曲折的现实</span></span></font></b><font face="微软雅黑"><span leaf="">。</span></font></p><p data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span leaf=""><br/></span></span></span></span></span></span></p><section data-pm-slice="0 0 []"><span><strong><span><span leaf="">02</span></span></strong></span></section><p><span><span><strong><b><font face="微软雅黑"><span leaf="" data-pm-slice="1 1 ["para",{"tagName":"p","attributes":{"class":"MsoNormal","style":"-webkit-tap-highlight-color: transparent; margin: 0px 16px; padding: 0px; outline: 0px; max-width: 100%; clear: both; min-height: 1em; color: rgba(0, 0, 0, 0.9); font-family: \"PingFang SC\", system-ui, -apple-system, \"system-ui\", \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif; font-size: 17px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.544px; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; background-color: rgb(255, 255, 255); text-align: center; line-height: 1.5em; box-sizing: border-box !important; overflow-wrap: break-word !important;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"b","attributes":{"style":null},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":null},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"font","attributes":{"face":"微软雅黑","style":null},"namespaceURI":"http://www.w3.org/1999/xhtml"}]">资本潮汐下的生存博弈</span></font></b></strong></span></span></p><p><span><strong><span><span leaf=""><br/></span></span></strong></span></p><p><font face="微软雅黑"><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/0kAgTXnvfia9rVsk9b8K2wMxO8FicFON4CmCoeiaPzGpGasYOwLoOOeZnqUKX3IQIlVwysxj8ZsDajAYgs7prp3bA/640?wx_fmt=png&from=appmsg" class="rich_pages wxw-img src" data-ratio="0.9480369515011547" data-s="300,640" data-type="png" data-w="866" type="block" data-imgfileid="513695950" src="./../../static/load.gif"/></span></font></p><p><font face="微软雅黑"><span leaf="">从战略分野到资本博弈，这对</span></font><span leaf="">Biotech双子星的故事还在资本的浪潮中不断演绎。</span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">整体而言，作为创新药领域的龙头企业，<span textstyle="">百济神州的全球化战略布局使其在市场上具有较高的预期和估值</span>。其成功撬动国际市场，泽布替尼在全球市场的放量，让投资者看到了其巨大的成长潜力，进而推动市值不断攀升。他的挑战是产品管线的下一个重磅炸弹在哪里？</span></font><span><p/></span></p><p><font face="微软雅黑"><span leaf="">而对于信达生物，其在国内市场的商业化模式较为成功，但在国际市场上的突破相对有限，市场对其未来增长的预期相对较为保守，这也导致其市值与百济神州存在较大差距。不过，<span textstyle="">信达生物在医保谈判、产品商业化以及本土创新等方面的优势，也为其实现市值增长提供了一定的基础和可能性</span>。</span></font><span><p/></span></p><p><font face="微软雅黑"><span leaf="">在</span></font><font face="微软雅黑"><span leaf="">资本与产业交织的</span></font><font face="微软雅黑"><span leaf="">近</span></font><font face="微软雅黑"><span leaf="">十年，中国创新药跻身全球</span></font><font face="微软雅黑"><span leaf="">第一梯队</span></font><font face="微软雅黑"><span leaf="">的同时，也经历了周期起伏的磨炼。对于国产</span></font><span leaf="">Biotech而言，本质上就是<span textstyle="">一场关乎生死的博弈</span>。</span></p><p><span leaf="">当极致的投资热情在短时间内爆发，资本洪流凶猛涌入创新药赛场，也有越来越多不同领域的Biotech找到了自己的位置，走出了自己的道路。</span></p><p><span leaf="">而这对双子星则被资本浪潮冲刷得愈发清晰。同样走过了15年，距离盈利同样仅一步之遥，但这种差异在研发投入图谱上尤为刺眼。</span><span><p/></span></p><p><span leaf="">2024年，百济神州研发投入<span textstyle="">19.53亿美元</span>，同比+9.8%，占营收比例约52%。这种近乎偏执的投入让百济短短7年，就<span textstyle="">烧掉了679亿元</span>，开展了超过140项临床试验。</span><span><p/></span></p><p><font face="微软雅黑"><span leaf="">而信达研发达到</span></font><span leaf=""><span textstyle="">26.8亿元</span>，同比增加了两成，销售及市场推广开支约为43.47亿元，同样是大手笔投入。但比起依靠大笔的对外授权收入或依赖某一大单品的商业化放量，<span textstyle="">信达生物的商业化模式，对于中国Biotech而言无疑更为稳定且持续，也更接近现实</span>。其PD-1在2019年进入医保后，销售额从10亿飙升至24.9亿，印证“以价换量”的成功方程式。</span></p><p><span leaf="">在出海上，信达生物选择“</span><b><font face="微软雅黑"><span leaf=""><span textstyle="">轻资产</span></span></font></b><font face="微软雅黑"><span leaf="">”运营，通过其子公司Fortvita来完成出海平台的构建，最大程度地降低成本与风险。</span></font><span><p/></span></p><p><font face="微软雅黑"><span leaf="">两人的差异最直接的体现在市值，百济神州高达</span></font><span leaf="">3333亿元、信达生物只有779亿元，资本市场的耐心也正在分野。这种估值逻辑的撕裂，折射出全球资本对中国创新药企的认知重构</span><font face="微软雅黑"><span leaf="">——<span textstyle="">技术突破的溢价正在碾压规模扩张的价值</span>。</span></font></p><p data-pm-slice="0 0 []"><font face="微软雅黑"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span data-pm-slice="0 0 []"><span leaf=""><br/></span></span></span></span></span></span></font></p><section data-pm-slice="0 0 []"><font face="微软雅黑"><span><strong><span><span leaf="">03</span></span></strong></span></font></section><p><span><span><strong><b><font face="微软雅黑"><b><span leaf="" data-pm-slice="1 1 ["para",{"tagName":"p","attributes":{"class":"MsoNormal","style":"-webkit-tap-highlight-color: transparent; margin: 0px 16px 24px; padding: 0px; outline: 0px; max-width: 100%; color: rgba(0, 0, 0, 0.9); font-family: \"PingFang SC\", system-ui, -apple-system, \"system-ui\", \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif; font-size: 17px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.544px; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; background-color: rgb(255, 255, 255); line-height: 1.5em; visibility: visible; box-sizing: border-box !important; overflow-wrap: break-word !important;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"b","attributes":{"style":null},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":null},"namespaceURI":"http://www.w3.org/1999/xhtml"}]">Biotech“造梦”</span></b></font></b></strong></span></span></p><p><span leaf=""><br/></span></p><p><b><span leaf="">回过头来，你会发现：以百济、信达为代表的</span><span leaf="">Biotech演化，本质上是全球医药产业链重构与中国医疗体系转型双重挤压下的产物。</span></b></p><p><b><span leaf="">信达与百济的战略分野，也映射出中国创新药领域突破的两种可能解，这是留给后来者的命题。</span></b></p><p><b><span leaf="">百济要做的是试图将中国Biotech嵌入全球价值链顶端。<span textstyle="">但连百济神州都不一定能再复制一个自己</span>。这也是为什么，虽然百济神州给出了一个成功的范本，但是在当下的资本市场环境下，几乎没有人能成功复制。</span></b><span><font face="微软雅黑"><span leaf=""><br/></span></font></span></p><p><span><font face="微软雅黑"><span leaf=""><span textstyle="">推荐阅读：</span><a href="https://mp.weixin.qq.com/s?__biz=MzA3OTYyMjk0MQ==&mid=2661177799&idx=1&sn=612f37c9319de046fa9d4e7ba8f8f533&scene=21#wechat_redirect" textvalue="谁会成为下一个百济神州？2025中国Biotech浮世绘" data-itemshowtype="0" target="_blank" linktype="text" data-linktype="2"><span textstyle="">谁会成为下一个百济神州？2025中国Biotech浮世绘</span></a></span></font></span></p><p><span><font face="微软雅黑"><span leaf=""><span textstyle="">信达的版本似乎更贴合本土</span></span></font><span leaf=""><span textstyle="">Biotech的成长</span>，并试图证明，在中国特有的“超级买方市场”中，通过医保谈判实现快速放量，再反哺创新投入的模式具有生命力。</span></span></p><p><span><span leaf="">但在探索医疗可及性与商业回报的微妙平衡中，信达</span></span><b><font face="微软雅黑"><span leaf="">也走过了</span></font><span leaf="">15年</span></b><span><font face="微软雅黑"><span leaf="">。</span></font></span></p><p><span><font face="微软雅黑"><span leaf="">即使如此，在中国创新药的</span></font><span leaf="">"黄金时代"与"资本寒冬"交替中，<span textstyle="">一大批Biotech依旧沿着百济-信达的战略光谱展开差异化突围</span>。</span></span></p><p><span><span leaf="">有诸如<span textstyle="">传奇生物、诺诚健华</span>，争当全球化赌局里的孤勇者。也有如<span textstyle="">君实生物、荣昌生物</span>，医保深水区的生存玩家。</span></span></p><p><span><span leaf="">当然还有一众Biotech走出属于自己的道路。所以，在这场生存游戏中，没有绝对的胜利模板。</span></span></p><p><span><span leaf="">正如百济用10年亏损换来首个"中美欧三地获批"的BTK抑制剂，信达通过多轮医保谈判构筑商业化护城河，<span textstyle="">每个造梦者都在寻找技术理想主义与商业现实主义的动态平衡点</span>。</span></span></p><p><span><span leaf="">而资本市场逐渐形成的共识是：能同时驾驭"全球创新价值"与"中国支付特色"的Biotech，才可能成为穿越周期的终极赢家。</span></span></p><p><span><span leaf="">Biotech“造梦”的故事还在继续......</span></span></p><p><span><strong><span leaf="">· END ·</span></strong></span></p><section><span><section><section><span><section><span><section data-role="paragraph"><section><span><strong><strong><span><span leaf="">--精彩推荐--</span></span></strong></strong></span></section></section><section><section data-role="paragraph"><section data-mpa-template="t"><section data-mid=""><section data-mid=""><section data-mid=""><section data-mid="" nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/ibl6u6nJ01g9icia42icDbWWvO2ObicnIUHjwQKVp30YzLS8xSInYupoEXAKjYeYDibY50CgKLz6ViaDjTjuRqUqaae0w/640?wx_fmt=other&wxfrom=5&wx_lazy=1&wx_co=1&tp=webp" alt="图片" data-ratio="2.2" data-type="png" data-w="20" data-imgfileid="513694590" class="src" src="./../../static/load.gif"/></section><section data-mid=""><p data-mid=""><span leaf="">       </span></p></section><section data-mid="" nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/K8beZoNWDcUm9I6ia4UU97K1XHrQx2PavruEm3xAL2W3Vd7JxrB8PLXtmT5JkwqpC9Dg9hEmtVZkY2hibnlkib0Qg/640?wx_fmt=other&wxfrom=5&wx_lazy=1&wx_co=1&tp=webp" alt="图片" data-ratio="2.2" data-type="png" data-w="20" data-imgfileid="513694589" class="src" src="./../../static/load.gif"/></section></section><section data-mid=""><section data-mid=""><p data-mid=""><span leaf=""><a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=1615313154836660234#wechat_redirect" textvalue="制药" target="_blank" linktype="text" data-linktype="2">制药</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3024249174126739458#wechat_redirect" textvalue="生物药" target="_blank" linktype="text" data-linktype="2">生物药</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3002464196128915463#wechat_redirect" textvalue="ADC" target="_blank" linktype="text" data-linktype="2">ADC</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3002459449720291329#wechat_redirect" textvalue="mRNA" target="_blank" linktype="text" data-linktype="2">mRNA</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3002443205952651265#wechat_redirect" textvalue="CAR-T" target="_blank" linktype="text" data-linktype="2">CAR—T</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3002448341810790402#wechat_redirect" textvalue="PD-1" target="_blank" linktype="text" data-linktype="2">PD-1</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3024203894601793537#wechat_redirect" textvalue="医械" target="_blank" linktype="text" data-linktype="2">医械</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2359840813347766272#wechat_redirect" textvalue="医疗影像" target="_blank" linktype="text" data-linktype="2">影像</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=1801750547474022402#wechat_redirect" textvalue="IVD" target="_blank" linktype="text" data-linktype="2">IVD</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2128417678607384578#wechat_redirect" textvalue="心血管" target="_blank" linktype="text" data-linktype="2">心血管</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=1677171839506186243#wechat_redirect" textvalue="骨科" target="_blank" linktype="text" data-linktype="2">骨科</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=1757045987518316549#wechat_redirect" textvalue="口腔" target="_blank" linktype="text" data-linktype="2">口腔</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2260036644655595531#wechat_redirect" textvalue="眼科" target="_blank" linktype="text" data-linktype="2">眼科</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3002429220515725312#wechat_redirect" textvalue="手术机器人" target="_blank" linktype="text" data-linktype="2">手术机器人</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=1365365676277465088#wechat_redirect" textvalue="互联网医疗" target="_blank" linktype="text" data-linktype="2">互联网医疗 </a>| <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3022632782998781957#wechat_redirect" textvalue="医院" target="_blank" linktype="text" data-linktype="2">医院</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2183399176783396870#wechat_redirect" textvalue="CXO" target="_blank" linktype="text" data-linktype="2">CXO</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=1801750547054592006#wechat_redirect" textvalue="生命科学" target="_blank" linktype="text" data-linktype="2">生命科</a><a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=1801750547054592006#wechat_redirect" textvalue="生命科学" target="_blank" linktype="text" data-linktype="2">学</a></span></p><p data-mid=""><span leaf=""><br/></span></p><p data-mid=""><span leaf=""><a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2832672981582856194#wechat_redirect" textvalue="深度原创" target="_blank" linktype="text" data-linktype="2">深度原创</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3002492305649680390#wechat_redirect" textvalue="年度盘点" target="_blank" linktype="text" data-linktype="2">年度盘点</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=1367447814363643905#wechat_redirect" textvalue="趋势分析" target="_blank" linktype="text" data-linktype="2">趋势分析</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2344366940171010051#wechat_redirect" textvalue="穿越周期系列" target="_blank" linktype="text" data-linktype="2">穿越周期系列</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003631045478694914#wechat_redirect" textvalue="股市动态" target="_blank" linktype="text" data-linktype="2">股市动态</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2351295140105027584#wechat_redirect" textvalue="企业动态" target="_blank" linktype="text" data-linktype="2">企业动态</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=1367401010544738305#wechat_redirect" textvalue="高管动态" target="_blank" linktype="text" data-linktype="2">高管动态</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003640491202297864#wechat_redirect" textvalue="医药财报" target="_blank" linktype="text" data-linktype="2">医药财报</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003672358517456899#wechat_redirect" textvalue="医械财报" target="_blank" linktype="text" data-linktype="2">医械财报</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003679889826496513#wechat_redirect" textvalue="重磅并购" target="_blank" linktype="text" data-linktype="2">重磅并购</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003689085217259525#wechat_redirect" textvalue="战略分拆" target="_blank" linktype="text" data-linktype="2">战略分拆</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2242465799951351809#wechat_redirect" textvalue="高管专访" target="_blank" linktype="text" data-linktype="2">高管专访</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3022671715367370753#wechat_redirect" textvalue="薪酬" target="_blank" linktype="text" data-linktype="2">薪酬</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2350286873681723393#wechat_redirect" textvalue="政策剖析" target="_blank" linktype="text" data-linktype="2">政策剖析</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003721956212588547#wechat_redirect" textvalue="医保谈判" target="_blank" linktype="text" data-linktype="2">医保谈判</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2260064956090155011#wechat_redirect" textvalue="DRG/DIP" target="_blank" linktype="text" data-linktype="2">DRG/DIP</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2780703935769903107#wechat_redirect" textvalue="集采" target="_blank" linktype="text" data-linktype="2">集采</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2242443317223620609#wechat_redirect" textvalue="JPM" target="_blank" linktype="text" data-linktype="2">JPM</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2167379646986715139#wechat_redirect" textvalue="最新闻" target="_blank" linktype="text" data-linktype="2">最新闻</a> <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2109156123130855424#wechat_redirect" textvalue="进博会" target="_blank" linktype="text" data-linktype="2">| 进博会</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003693980607561729#wechat_redirect" textvalue="CMEF" target="_blank" linktype="text" data-linktype="2">CMEF</a></span></p><p data-mid=""><span leaf=""><br/></span></p><p data-mid=""><span leaf=""><a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003734810613497857#wechat_redirect" textvalue="跨国医械榜单" target="_blank" linktype="text" data-linktype="2">医械榜单</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2138681969893834755#wechat_redirect" textvalue="美敦力" target="_blank" linktype="text" data-linktype="2">美敦力</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2283499658171908098#wechat_redirect" textvalue="雅培" target="_blank" linktype="text" data-linktype="2">雅培</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003861737651290115#wechat_redirect" textvalue="强生医疗" target="_blank" linktype="text" data-linktype="2">强生医疗</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2242425532166701057#wechat_redirect" textvalue="西门子医疗" target="_blank" linktype="text" data-linktype="2">西门子医疗</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2169034514042322948#wechat_redirect" textvalue="碧迪医疗" target="_blank" linktype="text" data-linktype="2">碧迪</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2260059219641237507#wechat_redirect" textvalue="史赛克" target="_blank" linktype="text" data-linktype="2">史赛克</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2129774610190565386#wechat_redirect" textvalue="GE医疗" target="_blank" linktype="text" data-linktype="2">GE医疗</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2821203400871936001#wechat_redirect" textvalue="罗氏诊断" target="_blank" linktype="text" data-linktype="2">罗氏诊断</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2110795304747794441#wechat_redirect" textvalue="飞利浦" target="_blank" linktype="text" data-linktype="2">飞利浦</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2260094232936054786#wechat_redirect" textvalue="波士顿科学" target="_blank" linktype="text" data-linktype="2">波士顿科学</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2471944836636770304#wechat_redirect" textvalue="迈瑞医疗" target="_blank" linktype="text" data-linktype="2">迈瑞医疗</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2217931670614310919#wechat_redirect" textvalue="联影医疗" target="_blank" linktype="text" data-linktype="2">联影医疗</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2260086349523582980#wechat_redirect" textvalue="微创医疗" target="_blank" linktype="text" data-linktype="2">微创医疗</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3005107520329465860#wechat_redirect" textvalue="乐普医疗" target="_blank" linktype="text" data-linktype="2">乐普医疗</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3005101524068581378#wechat_redirect" textvalue="威高" target="_blank" linktype="text" data-linktype="2">威高</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2260074340425924611#wechat_redirect" textvalue="丹纳赫" target="_blank" linktype="text" data-linktype="2">丹纳赫</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2259813152542687237#wechat_redirect" textvalue="赛默飞世尔" target="_blank" linktype="text" data-linktype="2">赛默飞</a></span></p><p data-mid=""><span leaf=""><br/></span></p><p data-mid=""><span leaf=""><a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003729508577034241#wechat_redirect" textvalue="跨国药企榜单" target="_blank" linktype="text" data-linktype="2">医药榜单</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2129909038019641349#wechat_redirect" textvalue="辉瑞" target="_blank" linktype="text" data-linktype="2">辉瑞</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2260054335843991556#wechat_redirect" textvalue="艾伯维" target="_blank" linktype="text" data-linktype="2">艾伯维</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2498030763310088193#wechat_redirect" textvalue="罗氏制药" target="_blank" linktype="text" data-linktype="2">罗氏制药</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3003852236730646531#wechat_redirect" textvalue="强生制药" target="_blank" linktype="text" data-linktype="2">强生制药</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2342994068991115265#wechat_redirect" textvalue="默沙东" target="_blank" linktype="text" data-linktype="2">默沙东</a> |  <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2259897844818247685#wechat_redirect" textvalue="阿斯利康" target="_blank" linktype="text" data-linktype="2">阿斯利康</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2657357893364908035#wechat_redirect" textvalue="百时美施贵宝" target="_blank" linktype="text" data-linktype="2">百时美施贵宝</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2240064293650300929#wechat_redirect" textvalue="赛诺菲" target="_blank" linktype="text" data-linktype="2">赛诺菲</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2109173613646970882#wechat_redirect" textvalue="诺华" target="_blank" linktype="text" data-linktype="2">诺华</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2281934524878159876#wechat_redirect" textvalue="葛兰素史克" target="_blank" linktype="text" data-linktype="2">葛兰素史克</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2161744830131994627#wechat_redirect" textvalue="恒瑞" target="_blank" linktype="text" data-linktype="2">恒瑞</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2242487491717234693#wechat_redirect" textvalue="百济神州" target="_blank" linktype="text" data-linktype="2">百济神州</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2890913037506035718#wechat_redirect" textvalue="石药集团" target="_blank" linktype="text" data-linktype="2">石药</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2260103259380252677#wechat_redirect" textvalue="信达生物" target="_blank" linktype="text" data-linktype="2">信达生物</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2366265609191161858#wechat_redirect" textvalue="君实生物" target="_blank" linktype="text" data-linktype="2">君实生物</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2259941097772941320#wechat_redirect" textvalue="传奇生物" target="_blank" linktype="text" data-linktype="2">传奇生物</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2260027264799342597#wechat_redirect" textvalue="天境生物" target="_blank" linktype="text" data-linktype="2">天境生物</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2145819390083203077#wechat_redirect" textvalue="基石药业" target="_blank" linktype="text" data-linktype="2">基石药业</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2259934290753093633#wechat_redirect" textvalue="荣昌生物" target="_blank" linktype="text" data-linktype="2">荣昌生物</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3022793336761597956#wechat_redirect" textvalue="再鼎医药" target="_blank" linktype="text" data-linktype="2">再鼎医药</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2209622228860796932#wechat_redirect" textvalue="药明康德" target="_blank" linktype="text" data-linktype="2">药明康德</a> | <a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2442474271202607105#wechat_redirect" textvalue="启明创投" target="_blank" linktype="text" data-linktype="2">启明创投</a></span><span><span leaf=""><a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=2442474271202607105#wechat_redirect" textvalue="启明创投" target="_blank" linktype="text" data-linktype="2"> | </a></span></span><span leaf=""><a href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=MzA3OTYyMjk0MQ==&action=getalbum&album_id=3022797521032822785#wechat_redirect" textvalue="礼来亚洲" target="_blank" linktype="text" data-linktype="2">礼来</a>亚洲</span></p></section></section></section></section></section></section></section></span></section></span></section></section></span><span><p/></span></section><p><mp-style-type data-value="3"/></p> 
        
         </article>
   <script type="text/javascript" src="./../../nav/jquery.lazyload.src.js"></script>
   <script type="text/javascript" charset="utf-8">
  $(function() {
      $("img.src").lazyload({ placeholder : "./../../static/load.gif",effect: "fadeIn"});
  });
</script>

    </div>
</main>



    <div class="footer" style="background-color: #ced3d6">

            <div class="w80 juzhong">
                <img class="wybf" src="./../../upload/images/footzhuban.png" style="width: 100%;z-index:99">
              <img class="sjbf" src="./../../upload/images/footzhuban1.png" style="width: 100%;z-index:99">
                    <p class="wybf" style="color: black" class="footer-copytxt">COPYRIGHT <a href="https://beian.miit.gov.cn/"  target="_blank">沪ICP备16029818号-3</a> GBAIE Co., Ltd. All right reserved  <br/>备案号：<a href="http://beian.miit.gov.cn/" target="_blank"><span style="color:black">沪ICP备16029818号-3</span></a>
                    </p>
                    <p class="sjbf" style="color: black;padding-top: 30px;text-align: center;clear: both;width: 90%;padding-left: 30px;" class="footer-copytxt"><a href="https://beian.miit.gov.cn/"  target="_blank">沪ICP备16029818号-3</a> COPYRIGHT <a href="https://beian.miit.gov.cn/"  target="_blank">沪ICP备16029818号-3</a> GBAIE Co., Ltd. All right reserved <br>
                    </p>
            </div>
	</div> 
    
    
<!-- 实现PC端右侧界面侧边栏 -->
    <ul id="scrollSearchDiv" class="rightline wybf" >
    <!--二维码图片div-->
        <li class="li2" ></li>
        <li class="li1" ></li>
        <div class="flex wybf"></div>
    <style type="text/css">
    	.li4::before {
          content:'\e612';
          font-size: 27px;
    	}
    </style>

        <div class="flex1 wybf">

        </div>
        <!--<li class="li4"></li>
        <div class="flex2 wybf"></div>-->
        <li class="li5"></li>
    </ul>
</body>
</html>